NASDAQ:VIVE Viveve Medical Earnings Date & Estimates $0.0002 0.00 (0.00%) As of 10/22/2026 09:37 AM Eastern Viveve Medical is estimated to report earnings on Friday, November 13, 2026. Research:Profile Upcoming Earnings Announcement Announcement DateNovember 13, 2026 Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Viveve MedicalViveve Medical is expected to post earnings of -$0.51 per share on revenue of $1.33 million. Viveve Medical has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.51Expected Revenue$1.33 millionRecent Track RecordLast ReportedQ3 2022Last Quarter EPS-$0.59Last Quarter Revenue$1.68 millionEPS Beat Rate6 of last 8 quartersPrepare for the Earnings CallCompany ProfileQ3 2022 Earnings ReportQ2 2022 Earnings ReportQ1 2022 Earnings Report Viveve Medical Earnings FAQ When does Viveve Medical report earnings? Viveve Medical (NASDAQ:VIVE) is estimated to report earnings on Friday, November 13, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Viveve Medical? Analysts expect Viveve Medical to post earnings of -$0.51 per share for the quarter. How much revenue is Viveve Medical expected to report? The consensus revenue estimate for Viveve Medical is $1.33 million for the quarter. Viveve Medical Earnings HeadlinesViveve Medical Inc.August 22, 2026 | marketwatch.comViveve Medical Inc (VIVE)July 24, 2024 | investing.comBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's happening again this year. And next year. And the year after that. The people who understand this are already moving. In a free presentation I just recorded, I'm revealing what we call "The 2026 AI Gold Rush." The ONE AI-linked asset class the U.S. government has no choice but to fuel… and BlackRock, Goldman Sachs, and 170 public companies are already positioning into it. The same strategy that delivered 12,480% for Mastercard investors since its 2006 IPO. Sitting idle isn't "playing it safe." It's the most expensive decision you'll make this decade. | Decentralized Masters (Ad)Incontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key CompaniesJuly 19, 2024 | finance.yahoo.comVaginal Rejuvenation Is Big BusinessJuly 19, 2024 | ca.style.yahoo.comVIVE Viveve Medical, Inc.July 29, 2023 | seekingalpha.comSee More Viveve Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Viveve Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viveve Medical and other key companies, straight to your email. Email Address About Viveve MedicalViveve Medical (NASDAQ:VIVE) was a women’s health company focused on developing and commercializing noninvasive treatments for vaginal health. Its principal product was the Viveve System, a medical device that used cryogen-cooled monopolar radiofrequency energy to heat and remodel tissue. The company promoted the system primarily for the treatment of vaginal laxity and related intimate-health concerns. The Viveve System was designed for use by healthcare professionals in office-based procedures and incorporated a disposable treatment tip. Viveve Medical sought regulatory clearances and commercial adoption in the United States and international markets, with distribution and clinical use reported in multiple countries. The company operated under the name Viveve, Inc. before adopting the Viveve Medical name. Publicly available information about its later operations, leadership, and current commercial activities is limited, and the company’s status and product availability may have changed since its period of public trading under the symbol VIVE.View Viveve Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestSpotify Soars After Earnings as the Company Touts AI Benefits and Moderating CostsPalantir's Next Big Test Isn't a Partnership—It's the NumbersKinder Morgan's $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings BeatCapital One Earnings: After a Double Beat the Rally Is OnTractor Supply's Q3 Beat Plants the Seeds for a Stock ReboundWD-40 Could Reward Patient Investors—Here's Why Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.